LDL pattern B means your blood carries a predominance of small, dense LDL cholesterol particles, each measuring 25.5 nanometers or less in diameter. This contrasts with pattern A, where larger, more buoyant LDL particles dominate. The distinction matters because these smaller particles behave differently inside your arteries and are linked to a higher risk of plaque buildup.
How Pattern B Differs From Pattern A
Not all LDL cholesterol is the same size. Your LDL particles exist on a spectrum, and the pattern you’re assigned reflects which size dominates. Pattern A means most of your LDL particles are larger than 25.5 nm in diameter. Pattern B means most are at or below that cutoff. There’s also an intermediate pattern (AB) for people who fall between the two.
The size difference is small in absolute terms, just a few nanometers, but it changes how these particles interact with your body. Two people can have identical LDL cholesterol numbers on a standard blood test, yet carry very different mixes of particle sizes. This is one reason some researchers argue that total LDL cholesterol alone doesn’t capture the full picture of cardiovascular risk.
Why Small, Dense LDL Is More Harmful
Small, dense LDL particles are more likely to contribute to atherosclerosis for three specific reasons. First, their smaller size allows them to penetrate the walls of your arteries more easily and get trapped there. Once inside the artery wall, they accumulate faster than larger particles. Second, they’re more susceptible to oxidation, a chemical process that makes them especially inflammatory and attractive to immune cells that form the core of arterial plaque. Third, your liver has a harder time clearing them from the bloodstream because they don’t bind as well to the receptors that normally pull LDL out of circulation.
This combination of easier entry, faster accumulation, greater oxidation, and slower clearance is what makes pattern B a concern beyond what a standard cholesterol number reveals.
The Metabolic Profile Behind Pattern B
Pattern B rarely shows up in isolation. It tends to cluster with a specific set of metabolic changes tied to insulin resistance. In studies comparing pattern A and pattern B individuals, those with small, dense LDL consistently had higher triglycerides (averaging about 175 mg/dL versus 68 mg/dL in pattern A), lower HDL cholesterol, higher fasting glucose, higher insulin levels, and higher blood pressure.
This cluster is sometimes called the “atherogenic lipid triad”: high triglycerides, low HDL, and small dense LDL. The underlying driver is often insulin resistance, the same metabolic dysfunction behind type 2 diabetes and metabolic syndrome. When your body struggles to process insulin efficiently, the liver produces more triglyceride-rich particles, and through a chain of exchanges between lipoproteins in the blood, your LDL particles end up smaller and denser. So pattern B is often a visible marker of a deeper metabolic problem rather than a standalone issue.
How Pattern B Is Detected
A standard lipid panel (total cholesterol, LDL, HDL, and triglycerides) does not tell you your LDL particle size. Determining whether you have pattern A or B requires specialized testing. The most common methods include gradient gel electrophoresis, which separates particles by size; NMR spectroscopy, which counts actual particle numbers and measures average particle size; and ultracentrifugation-based tests like the VAP, which separate particles by density.
Each method gives slightly different information. NMR provides a particle count (how many LDL particles per liter of blood), while the other methods focus more on size distribution. Because these tests use different technologies, their results don’t always line up perfectly, and there aren’t universally standardized reference ranges across methods. This is one reason major guidelines haven’t made LDL subfraction testing a routine recommendation yet.
The 2018 multi-society cholesterol guidelines still recommend a standard lipid panel as the primary screening tool. However, they acknowledge that when LDL particle count and standard LDL cholesterol disagree, which happens frequently in people with metabolic syndrome or diabetes, cardiovascular risk tends to track more closely with particle count. Some clinicians order these advanced tests for patients whose standard numbers look acceptable but who have other risk factors suggesting pattern B might be present.
What Shifts LDL Toward Pattern B
The biggest dietary and lifestyle drivers of pattern B overlap heavily with the factors behind insulin resistance and high triglycerides. Diets high in refined carbohydrates and sugar tend to raise triglycerides, which in turn promotes the formation of small, dense LDL. Excess body weight, particularly visceral fat around the midsection, compounds this effect. Sedentary behavior is another contributor.
The relationship between dietary fat and LDL pattern is more nuanced than it might seem. In a randomized trial of healthy young women, a ketogenic low-carb, high-fat diet increased both large buoyant LDL and small dense LDL cholesterol, along with ApoB (a marker of total atherogenic particle count). One participant who started with pattern B shifted to pattern A, but participants who already had pattern A also saw their small dense LDL rise. So very low-carb diets don’t reliably eliminate small dense LDL, and they can raise overall LDL in ways that may offset any improvement in particle size.
How Exercise and Diet Affect Particle Size
Aerobic exercise is one of the most effective ways to shift LDL particles from small and dense to large and buoyant. In a study that tested calorie restriction alone versus calorie restriction plus exercise, diet alone produced only a slight reduction in small dense particles. Adding regular aerobic exercise (about 45 minutes, five days a week) led to a much more significant decrease. Average LDL particle diameter increased from 24.2 nm to 25.1 nm, crossing the threshold from pattern B territory into pattern A. This improvement correlated strongly with reductions in triglycerides.
That triglyceride connection is key. Anything that lowers your triglycerides, whether exercise, weight loss, or reduced sugar and refined carbohydrate intake, tends to improve your LDL particle size as well. The two move together because they share the same metabolic pathways.
Medications and LDL Particle Size
Statins and fibrates both affect small dense LDL, but in different ways. In a randomized crossover trial, a fibrate reduced small LDL particle count by 32% while slightly increasing large LDL particles, effectively shifting the size distribution toward pattern A. Average LDL particle size increased from 20.4 nm to 20.8 nm. A statin reduced both small and large LDL particles (34% and 19% respectively), lowering the total number across the board rather than specifically shifting the ratio.
The statin came out ahead on one important measure: the ratio of atherogenic to protective lipoprotein particles (LDL-to-HDL particle ratio) improved with the statin but not with the fibrate. This suggests that while fibrates are better at specifically targeting small dense LDL, statins may provide a more comprehensive reduction in overall cardiovascular risk. In practice, treatment decisions depend on your full metabolic profile, not just particle size alone.
What Pattern B Means for Your Risk
The relationship between pattern B and heart disease risk is real but more complex than a simple “pattern B equals danger” message. In large epidemiologic studies, small dense LDL has been a stronger predictor of cardiovascular disease than standard LDL cholesterol. But in a study of patients who had already suffered a heart attack, pattern B was not independently associated with higher cardiovascular mortality after adjusting for other risk factors like blood pressure, diabetes, inflammation, and metabolic syndrome.
This likely reflects the fact that pattern B is tightly intertwined with those other risk factors. It’s part of a metabolic package. Treating the package, through weight loss, exercise, triglyceride reduction, and blood sugar management, tends to improve the particle pattern along with everything else. For most people, knowing you have pattern B is less about adding a new medication and more about recognizing that your metabolism needs broader attention.